((自动化翻译由路透提供,请见免责声明 ))
路透11月6日 - Avid Bioservices 周三表示,该公司已同意被GHO Capital Partners和Ampersand Capital Partners管理的基金收购,交易价值约为11亿美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.